Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial

BACKGROUND: Heavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids. We compared the effectiveness of ulipristal acetate and the levonorgestrel-releasing intrauterine system at redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitaker, Lucy H.R., Middleton, Lee J., Daniels, Jane P., Williams, Alistair R.W., Priest, Lee, Odedra, Smita, Cheed, Versha, Stubbs, Clive E., Clark, T. Justin, Lumsden, Mary-Ann, Hapangama, Dharani K., Bhattacharya, Siladitya, Smith, Paul P., Nicholls, Elaine P., Roberts, Neil, Semple, Scott I., Saraswat, Lucky, Walker, Jane, Chodankar, Rohan R., Critchley, Hilary O.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209678/
https://www.ncbi.nlm.nih.gov/pubmed/37251622
http://dx.doi.org/10.1016/j.eclinm.2023.101995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209678/
https://www.ncbi.nlm.nih.gov/pubmed/37251622
http://dx.doi.org/10.1016/j.eclinm.2023.101995

Ejemplares similares